SAB Biotherapeutics, Inc. Common Stock (SABS)

Typically moves ±15.34% on earnings
EARNINGS ANALYTICS
search

SAB Biotherapeutics, Inc. Common Stock (SABS) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -9.7% (Nov 22, 2021) and its biggest decline was -20.98% (Mar 31, 2023).

Earnings reactions

How SABS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±15.34%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Mar 31, 2023 ☽ POST -20.98% open_in_new
Nov 22, 2021 ☀ PRE -9.7% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±15.34%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 16 →
16
Funds holding
$21192908
Total value held
Buying
14 added · 2 reduced
Blackrock, Inc.
$11957462 +917.51%
Ameriprise Financial Inc
$2382975 NEW BUY
State Street Corp
$2070241 +615.11%
Ubs Group Ag
$1427009 NEW BUY
Northern Trust Corp
$1413707 +531.23%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
424B3 20260821 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G 20260812 open_in_new SEC.gov
SCHEDULE 13D/A 20260810 open_in_new SEC.gov
10-Q 20260806 open_in_new SEC.gov

Frequently asked about SABS earnings

How much does SABS stock move after earnings? expand_more

Over 2 reports, SABS has moved an average of ±15.34% the session after earnings, closing higher 0.0% of the time.

What was SABS's biggest post-earnings move? expand_more

SABS's largest post-earnings gain on record was -9.7% on Nov 22, 2021, and its largest decline was -20.98% on Mar 31, 2023.

Where can I find SAB Biotherapeutics, Inc. Common Stock's SEC filings? expand_more

All of SAB Biotherapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers